Your browser doesn't support javascript.
loading
Genetic factors influencing the risk of multiple myeloma bone disease.
Johnson, D C; Weinhold, N; Mitchell, J; Chen, B; Stephens, O W; Försti, A; Nickel, J; Kaiser, M; Gregory, W A; Cairns, D; Jackson, G H; Hoffmann, P; Noethen, M M; Hillengass, J; Bertsch, U; Barlogie, B; Davis, F E; Hemminki, K; Goldschmidt, H; Houlston, R S; Morgan, G J.
Affiliation
  • Johnson DC; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Weinhold N; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Mitchell J; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Chen B; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Stephens OW; German Cancer Research Center, Heidelberg, Germany.
  • Försti A; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Nickel J; German Cancer Research Center, Heidelberg, Germany.
  • Kaiser M; Center for Primary Health Care Research, Lund University, Malmö, Sweden.
  • Gregory WA; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Cairns D; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Jackson GH; Leeds Institute of Molecular Medicine, Section of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Hoffmann P; Leeds Institute of Molecular Medicine, Section of Clinical Trials Research, University of Leeds, Leeds, UK.
  • Noethen MM; Department of Haematology, Newcastle University, Newcastle-Upon-Tyne, UK.
  • Hillengass J; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Bertsch U; Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.
  • Barlogie B; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Davis FE; Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
  • Hemminki K; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Goldschmidt H; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Houlston RS; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Morgan GJ; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Leukemia ; 30(4): 883-8, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26669972
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Diseases / Biomarkers, Tumor / Polymorphism, Single Nucleotide / Osteoprotegerin / Multiple Myeloma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Diseases / Biomarkers, Tumor / Polymorphism, Single Nucleotide / Osteoprotegerin / Multiple Myeloma Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido